Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: a question of drug, timing or both?

Affiliations

• ¹ Department of Radiation Oncology and DITEP, Gustave Roussy, University Hospital, Université Paris-Saclay, INSERM 1030 Molecular Radiotherapy, Villejuif, France [email protected].
• ² Department of Radiation Oncology and DITEP, Gustave Roussy, University Hospital, Université Paris-Saclay, INSERM 1030 Molecular Radiotherapy, Villejuif, France.